Novavax
NVAX
NVAX
140 hedge funds and large institutions have $77.8M invested in Novavax in 2019 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 52 increasing their positions, 36 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
59% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 46
73% less capital invested
Capital invested by funds: $290M → $77.8M (-$213M)
Holders
140
Holding in Top 10
–
Calls
$28.6M
Puts
$7.08M
Top Buyers
| 1 | +$2.77M | |
| 2 | +$2.41M | |
| 3 | +$1.3M | |
| 4 |
Renaissance Technologies
New York
|
+$1.1M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.01M |
Top Sellers
| 1 | -$8.68M | |
| 2 | -$8.63M | |
| 3 | -$5.52M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$5.17M |
| 5 |
State Street
Boston,
Massachusetts
|
-$3.81M |